secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ultragenyx Pharmaceutical Inc. (RARE)
CIK:        0001515673
Form:       8-K
Filed at:   2022-11-10T23:59:59+00:00
Accession:  0001193125-22-282661
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ultragenyx CFO Mardi Dier resigns effective Nov 15; search underway
-------------------------------------------------------------------

- Mardi Dier voluntarily resigns as EVP and CFO effective November 15, 2022.
- Company has commenced a formal search for a new CFO.
- Dier leaves to pursue another opportunity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1515673/000119312522282661/0001193125-22-282661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1515673/000119312522282661/d407323d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-282661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer